Medical News

RSS

AMRI, Genentech enter research and licensing collaboration

AMRI announced today a research and licensing agreement with Genentech, a member of the Roche Group, for a family of antibacterial compounds discovered from AMRI's proprietary research of its natural products sample collection.

5 Jan 2011

Senate Dems line up against the effort to undo the health overhaul

In the Senate, Democratic leaders pledge to block any House attempt at repeal and cite the health measure's benefits for seniors as key reason.

5 Jan 2011

Spectrum submits FUSILEV sNDA for treatment of colorectal cancer

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced it submitted a supplemental New Drug Application with the U.S. Food and Drug Administration (FDA) for a Ready-to-Use formulation of FUSILEV (levoleucovorin) for Injection.

5 Jan 2011

Levindale's Specialty Hospital inagurates high intensity unit

The Specialty Hospital at Levindale has opened Maryland's first high intensity unit inside a chronic hospital. This unit provides heart monitoring for patients who require specialized medical care and treatment for serious illnesses and/or injuries.

5 Jan 2011

Dutch scientists provide new insights into intestinal cancer through plant study

Dutch scientists have gained important new insights into intestinal cancer from studying a plant. The disease is called Peutz-Jeghers Syndrome, a hereditary disorder where people develop intestinal polyps that turn into malignant tumors.

5 Jan 2011

Towers Watson acquires Aliquant

Towers Watson, a leading global professional services company, announced today the completion of its acquisition of Aliquant, a privately held, full-service health and welfare benefits administration outsourcing firm. The acquisition enables Towers Watson to strengthen its position as a premier provider of high-quality health and welfare benefits outsourcing services.

5 Jan 2011

FDA lifts clinical hold on Hemispherx's Alferon LDO Phase II study for influenza prevention

Hemispherx Biopharma, Inc. announced today that the Food and Drug Administration (FDA) has lifted a clinical hold on its Phase II, double-blind, adaptive-design, randomized, placebo-controlled, dose-ranging study of Alferon® LDO [oral interferon alfa-n3 (human leukocyte derived)] for the prevention and treatment of influenza.

5 Jan 2011

Opinions: U.S. International Affairs Budget; Health impacts of climate change; Role of U.N.; Drug development, free trade

Despite challenging economic times, "[t]wo areas we cannot afford to shortchange right now ... are our national security and our economic prosperity, which is why we must continue to have a strong and effective International Affairs Budget," U.S. Global Leadership Coalition Communications Director Richard Parker writes in a FoxNews.com opinion piece.

5 Jan 2011

Pico-Tesla announces expansion of Magneceutical Phase III trail for Parkinson's disease

Pico-Tesla, The Magneceutical Company, announced that it has expanded its ongoing Phase III pivotal clinical trial by adding three Principal Investigators, including two university-affiliated clinicians: one in Denver; and one in Tampa.

5 Jan 2011

Tiny light source and sensors in endoscope may detect esophageal cancer more accurately

A tiny light source and sensors at the end of an endoscope may provide a more accurate way to identify pre-cancerous cells in the lining of the esophagus.

4 Jan 2011

Today's Opinions: GOP rerun; Finding bipartisanship; Pawlenty's legacy

You just can't close the door on this crowd. The party that brought us the worst economy since the Great Depression, that led us into Iraq and the worst foreign policy disaster in American history, that would like to take a hammer to Social Security and a chisel to Medicare, is back in control of the House of Representatives with the expressed mission of undermining all things Obama (Bob Herbert, 1/3).

4 Jan 2011

Boston Scientific acquires Sadra Medical

Boston Scientific Corporation today announced the completion of its acquisition of Sadra Medical, Inc. of Los Gatos, California. The transaction follows the definitive merger agreement announced on November 19, 2010.

4 Jan 2011

Bioniche Life Sciences announces completion of Australian Offer and raises gross proceeds of A$12.5 million

Bioniche Life Sciences In., a research-based, technology-driven Canadian biopharmaceutical company, today announced that it has successfully completed its Australian Offer of 8.6 million CHESS Depositary Instruments at A$1.45 per CDI, raising gross proceeds of A$12.5 million.

4 Jan 2011

Anadys begins ANA598 Phase IIb study for hepatitis C

Anadys Pharmaceuticals, Inc. announced today that it has initiated the planned Phase IIb study of ANA598 in combination with pegylated interferon and ribavirin. The protocol for the study has been cleared by the United States Food and Drug Administration and Health Canada.

4 Jan 2011

FDA approves ImmunoCellular Therapeutics IND amendment for ICT-107 Phase II clinical trial

ImmunoCellular Therapeutics, Ltd., a biotechnology company that is developing immune-based therapies for the treatment of various forms of cancer, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's Investigational New Drug (IND) amendment to conduct a Phase II clinical trial in the U.S. of ICT-107, the company's dendritic cell based cancer vaccine candidate for the treatment of glioblastoma multiforme (GBM).

4 Jan 2011

TRPM2 in pancreatic beta-cells may control insulin secretion levels

The research group led by professor Makoto Tominaga and Dr. Kunitoshi Uchida, National institute for Physiological Sciences, found TRPM2 ion channel in pancreatic beta-cells is important for insulin secretion stimulated by glucose and gastrointestinal hormone secreted after food intake. Their finding was reported in Diabetes.

4 Jan 2011

Vaccine blocks cocaine high in mice - human trials likely

Researchers have produced a lasting anti-cocaine immunity in mice by giving them a safe vaccine that combines bits of the common cold virus with a particle that mimics cocaine.

4 Jan 2011

Flu outbreak peak yet to come: Experts

Parents of kids returning to school in the UK after Christmas holidays have been warned of a surge in flu cases. Professor John Oxford, a leading virologist at St Bartholomew’s and the Royal London Hospital explained that children returning to school in the past prompted a rise in the number of flu cases. “You tend to get a surge,” the professor said. “I would anticipate a surge, but how long that will last is difficult to say.” He added, “This virus is not going to go away next week. Even if it’s already peaked, it’s still going to be around for the next couple of weeks and it’s still worthwhile being vaccinated at this stage.”

4 Jan 2011

NHS wastes £1bn on supplier rates: Report

The head of a cost-cutting programme revealed that eight NHS trusts are routinely paying 19 different sums for the same pacemaker – a discrepancy that is wasting up to £750 a time.

4 Jan 2011

Hepatitis A scare at Long Island church

Health officials have warned that parishioners who received Holy Communion during Christmas Mass at a church on Long Island may have been exposed to hepatitis A and may need vaccinated as soon as possible. Particularly those who received Communion at the 10.30am and 12pm (local time) masses on December 25, 2010, at Our Lady of Lourdes Church in Massapequa Park should get the shots.

4 Jan 2011

Medical News

AMRI, Genentech enter research and licensing collaboration

Senate Dems line up against the effort to undo the health overhaul

Spectrum submits FUSILEV sNDA for treatment of colorectal cancer

Levindale's Specialty Hospital inagurates high intensity unit

Dutch scientists provide new insights into intestinal cancer through plant study

Towers Watson acquires Aliquant

FDA lifts clinical hold on Hemispherx's Alferon LDO Phase II study for influenza prevention

Opinions: U.S. International Affairs Budget; Health impacts of climate change; Role of U.N.; Drug development, free trade

Pico-Tesla announces expansion of Magneceutical Phase III trail for Parkinson's disease

Tiny light source and sensors in endoscope may detect esophageal cancer more accurately

Today's Opinions: GOP rerun; Finding bipartisanship; Pawlenty's legacy

Boston Scientific acquires Sadra Medical

Bioniche Life Sciences announces completion of Australian Offer and raises gross proceeds of A$12.5 million

Anadys begins ANA598 Phase IIb study for hepatitis C

FDA approves ImmunoCellular Therapeutics IND amendment for ICT-107 Phase II clinical trial

TRPM2 in pancreatic beta-cells may control insulin secretion levels

Vaccine blocks cocaine high in mice - human trials likely

Flu outbreak peak yet to come: Experts

NHS wastes £1bn on supplier rates: Report

Hepatitis A scare at Long Island church

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News